Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q3 2024 Earnings

7AugConfirmed

Q4 2023

Q2 2024

Q3 2024

-3.75

-2.72

-1.7

-0.67

Details

Expected EPS

-0.949713

Actual EPS

-0.86

Surprise EPS

0.09

Surprise Percent

+9.45%

Description

Spyre Therapeutics (3920.F) has reported earnings of -0.86 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.